Vismodegib in Treating Patients With Advanced Chondrosarcomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Centre Leon Berard
Ricoh USA, Inc.
Quironsalud
Istituto Ortopedico Rizzoli
Var2 Pharmaceuticals
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
UNICANCER
Medical College of Wisconsin
Eli Lilly and Company
IGM Biosciences, Inc.
TopAlliance Biosciences
Centre Antoine Lacassagne
Grupo Espanol de Investigacion en Sarcomas
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Stanford University
Tracon Pharmaceuticals Inc.
Eastern Cooperative Oncology Group
Grupo Espanol de Investigacion en Sarcomas
Emerald Clinical Inc.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Genentech, Inc.
Celgene
Peking University People's Hospital
Washington University School of Medicine
N.N. Petrov National Medical Research Center of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Peking University People's Hospital
AEterna Zentaris
Assaf-Harofeh Medical Center
Massachusetts General Hospital
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Novartis
Celldex Therapeutics
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
University of South Florida
INSYS Therapeutics Inc
National Cancer Institute (NCI)